It provides enough doses for meaningful protocol duration without the waste risk of larger vials at lower doses
A recent cross-sectional study involving 124 participants indicated that 56% of patients still exhibited elevated residual gastric contents despite halting incretin agonists for a minimum of 7 days, thus challenging the practice of discontinuing long-acting GLP-1 RAs solely for this duration prior to surgery [19]
In phase 2 clinical trials, 2% of patients reported pancreatitis with a 12 mg dose
7 Powerful Morning Routines for GLP1 Success to Support a Positive Weight Management Journey
Liraglutide was finally approved in 2010 for the treatment of patients with type 2 diabetes unable to regulate their blood sugar with other insulin medications (Gilbert, Rosenthal, Jan 2024)
In a state where the obesity rate ranks among the highest in the country, many health providers were thrilled when Mississippi Medicaid in 2023 began covering GLP-1s for people 12 and older